Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome

Combination of High-Dose Methylprednisolone and Defibrotide for Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplant Recipients

(2018) Nicholas J. Gloude et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study

(2017) Hagop M Kantarjian et al.   Lancet Haematology

Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research

(2016) Christopher Strouse et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program

(2016) Selim Corbacioglu et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

(2016) P. G. Richardson et al.   BLOOD

What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance

(2016) M. Palomo et al.   BLOOD

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

(2016) M Mohty et al.   BONE MARROW TRANSPLANTATION

Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes

(2015) K Yakushijin et al.   BONE MARROW TRANSPLANTATION

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

(2015) M Mohty et al.   BONE MARROW TRANSPLANTATION

Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen

(2014) P D Tsirigotis et al.   BONE MARROW TRANSPLANTATION

BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation

(2013) Fiona L. Dignan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Defibrotide: Properties and clinical use of an old/new drug

(2013) R. Pescador et al.   VASCULAR PHARMACOLOGY

High-Dose Methylprednisolone for Veno-Occlusive Disease of the Liver in Pediatric Hematopoietic Stem Cell Transplantation Recipients

(2012) Kasiani C. Myers et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Drug safety evaluation of defibrotide

(2012) Paul G Richardson et al.   Expert Opinion On Drug Safety

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial

(2012) Selim Corbacioglu et al.   LANCET

Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation

(2012) Selim Corbacioglu et al.   Expert Review of Hematology

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial

(2010) Paul G. Richardson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome

(2009) Jason A. Coppell et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity

(2009) Cinara L Echart et al.   BLOOD COAGULATION & FIBRINOLYSIS

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

(2008) C. Cutler et al.   BLOOD

Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease

(2008) L. Benimetskaya et al.   BLOOD